Fulcrum Therapeutics Inc Financial Flexibility Index
Fulcrum Therapeutics Inc financial flexibility index. Fulcrum Therapeutics Inc (FULC) has a Financial Flexibility Index of -0.85x as of September 2025. Free cash flow of $-14.10 Million (operating CF $-14.19 Million minus capex $90.00K) represents -1% of total liabilities ($16.49 Million). See Fulcrum Therapeutics Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Fulcrum Therapeutics Inc (2017–2024)
Financial flexibility index of Fulcrum Therapeutics Inc from 2017 to 2024. Historical Financial Flexibility Index trend for Fulcrum Therapeutics Inc across 8 annual periods. Check Fulcrum Therapeutics Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Fulcrum Therapeutics Inc Financial Flexibility Index by Year (2017–2024)
Fulcrum Therapeutics Inc financial flexibility index by year from 2017 to 2024. Year-by-year free cash flow to debt coverage for Fulcrum Therapeutics Inc. For the full cash flow conversion analysis, see FULC cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.11x | $-1.94 Million | $-2.22 Million | $17.68 Million | ▲ +97.3% |
| 2023 | -4.02x | $-90.46 Million | $-90.97 Million | $22.50 Million | ▼ -17.3% |
| 2022 | -3.43x | $-95.09 Million | $-97.05 Million | $27.74 Million | ▼ -4.7% |
| 2021 | -3.27x | $-76.77 Million | $-78.48 Million | $23.46 Million | ▼ -115.1% |
| 2020 | -1.52x | $-52.31 Million | $-53.66 Million | $34.40 Million | ▲ +8.3% |
| 2019 | -1.66x | $-38.63 Million | $-39.48 Million | $23.29 Million | ▼ -19.4% |
| 2018 | -1.39x | $-13.58 Million | $-22.56 Million | $9.77 Million | ▲ +76.9% |
| 2017 | -6.02x | $-18.17 Million | $-20.07 Million | $3.02 Million | — |